Projects per year
Fingerprint
Dive into the research topics where Evanthia Galanis is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
-
P-1: The Role of CHFR in Tumorigenesis and Paclitaxwl-Sensitivity in Breast Cance
Vachon, C. M., Suman, V. J., Lingle, W. L., Chen, J., Goetz, M. P., Gendler, S. J., Lingle, W. L., Suman, V. J., Haluska, P. R. J., Couch, F. J., Couch, F. J., Vachon, C. M., Visscher, D. W., Hawse, J. R. & Galanis, E.
National Institutes of Health, National Cancer Institute
7/1/05 → 8/31/21
Project: Research project
-
Novel multipronged Immunovirotherapy Approach for GBM Treatment
Project: Research project
-
Measles Virotherapy and radiovirotherapy in the Treatment of recurrent gliomas
Galanis, E., Kinney, L. & Kinney, L.
1/1/11 → 12/31/15
Project: Research project
-
Optimizing Measles Virotherapy in the Treatment of Ovarian Cancer
Galanis, E., Peng, K., Kinney, L. & Kinney, L.
6/1/09 → 12/31/14
Project: Research project
Research output
-
Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance
Jalalirad, M., Haddad, T. C., Salisbury, J. L., Radisky, D., Zhang, M., Schroeder, M., Tuma, A., Leof, E., Carter, J. M., Degnim, A. C., Boughey, J. C., Sarkaria, J., Yu, J., Wang, L., Liu, M. C., Zammataro, L., Malatino, L., Galanis, E., Ingle, J. N., Goetz, M. P. & 1 others, , Apr 8 2021, In: Oncogene. 40, 14, p. 2509-2523 15 p.Research output: Contribution to journal › Article › peer-review
Open Access -
CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design
Jaeckle, K. A., Ballman, K. V., van den Bent, M., Giannini, C., Galanis, E., Brown, P. D., Jenkins, R. B., Cairncross, J. G., Wick, W., Weller, M., Aldape, K. D., Dixon, J. G., Anderson, S. K., Cerhan, J. H., Wefel, J. S., Klein, M., Grossman, S. A., Schiff, D., Raizer, J. J., Dhermain, F. & 3 others, , Mar 25 2021, In: Neuro-oncology. 23, 3, p. 457-467 11 p.Research output: Contribution to journal › Article › peer-review
2 Scopus citations -
Gemogenovatucel-T (Vigil) immunotherapy demonstrates clinical benefit in homologous recombination proficient (HRP) ovarian cancer
Rocconi, R. P., Monk, B. J., Walter, A., Herzog, T. J., Galanis, E., Manning, L., Bognar, E., Wallraven, G., Stanbery, L., Aaron, P., Senzer, N., Coleman, R. L. & Nemunaitis, J., Jun 2021, In: Gynecologic oncology. 161, 3, p. 676-680 5 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Parameters of immunoglobulin extraction from dried blood spot cards and immunoassays for detection of antibody response to pathogens including the novel SARS-CoV-2
Iankov, I., Viker, K., Turgeon, C., Matern, D. & Galanis, E., May 2021, In: Journal of Immunological Methods. 492, 112996.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Proof of principle study of sequential combination atezolizumab and Vigil in relapsed ovarian cancer
Rocconi, R. P., Stevens, E. E., Bottsford-Miller, J. N., Ghamande, S. A., Elder, J., DeMars, L. L., Munkarah, A., Aaron, P., Stanbery, L., Wallraven, G., Bognar, E., Manley, M., Horvath, S., Manning, L., Walter, A., Galanis, E., Herzog, T., Monk, B. J., Coleman, R. L. & Nemunaitis, J., 2021, (Accepted/In press) In: Cancer Gene Therapy.Research output: Contribution to journal › Article › peer-review